BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Infographics: Dynamic digital data analysis
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Israel
Rise of obesity
Radiopharmaceuticals
Biosimilars
Aging
IVDs on the rise
Coronavirus
Artificial intelligence
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, December 12, 2024
See today's BioWorld
Home
» Biopharma's near-term political destiny marred by uncertainty, need to reach the public
X
Upgrade your daily dose of biopharma and medtech news
Subscribe to BioWorld™ news services
See subscription options
To read the full story,
subscribe
or
sign in
.
Take it to the streets
Biopharma's near-term political destiny marred by uncertainty, need to reach the public
Jan. 14, 2020
By
Michael Fitzhugh
No Comments
SAN FRANCISCO – There's no time like now to think about the potential political changes, opportunities and challenges down the road for industry, Hogan Lovells partner Ivan Zapien told luncheon attendees during this year's Biotech Showcase.
BioWorld
Conferences